Real estate remains one of the most debated corners of the market as investors weigh higher-for-longer financing costs against durable rental income. Within this sector, two exchange-traded funds (ETFs) take fundamentally different paths: NURE, the Nuveen Short-Term REIT ETF, and REET, the iShares Global REIT ETF. Comparing these funds is timely because they illustrate two opposing approaches to real estate exposure. NURE concentrates on a narrow slice of U.S. REITs with short lease durations, betting on rapid rent repricing, while REET captures the entire global listed-property universe. For investors building or rebalancing a real estate sleeve, the choice between concentrated thematic positioning and diversified global coverage is a core structural decision.
NURE is a passively managed fund that tracks the Dow Jones U.S. Select Short-Term REIT Index. Its objective is to isolate U.S. equity REITs (real estate investment trusts) that generate cash flows from short-duration leases. The index is a subset of the broader Dow Jones U.S. Select REIT Index and includes REITs concentrated in apartments, hotels, self-storage, and manufactured home communities—property types whose leases typically reset more frequently than office or industrial contracts.
The fund holds roughly 30 securities, weighted by float-adjusted market capitalization with a 5% cap on any single name. Holdings are rebalanced quarterly. The portfolio is 100% U.S.-domiciled, and its top positions include HST (Host Hotels & Resorts), RHP (Ryman Hospitality Properties), EXR (Extra Space Storage), PSA (Public Storage), SUI (Sun Communities), and AMH (American Homes 4 Rent). The expense ratio is 0.35%. Its defining feature is concentration: a small, top-heavy portfolio whose short-lease tilt makes it more responsive to changes in occupancy, travel demand, and apartment rent trends than a broad REIT fund.
REET is a passively managed fund tracking the FTSE EPRA Nareit Global REITs Index, which captures publicly listed REITs and their local equivalents across developed and emerging markets. This gives investors one-ticket access to the global income-producing property universe, spanning industrial warehouses, retail, healthcare, data centers, residential, offices, and specialty property types.
The fund holds roughly 350 securities, reviewed and rebalanced quarterly on a market-capitalization basis. While a majority of assets are U.S.-listed, REET also carries meaningful exposure to international REITs in markets such as Australia, Japan, and the United Kingdom. Its largest positions include WELL (Welltower), PLD (Prologis), EQIX (Equinix), DLR (Digital Realty Trust), SPG (Simon Property Group), and O (Realty Income). The expense ratio is 0.14%, and the fund's scale—several billion dollars in assets under management (AUM)—supports tight trading spreads and robust liquidity. Its defining feature is breadth, which reduces single-property-type and single-country concentration risk.
Both funds operate in a real estate environment shaped by the interaction of interest rates, rental growth, and capital allocation. Elevated borrowing costs have pressured property values and development activity, but they have also constrained new supply, supporting occupancy and rent growth in sectors such as apartments, self-storage, and industrial logistics. Data centers and healthcare properties have attracted significant investor interest tied to secular themes in artificial intelligence and aging demographics.
The regulatory and macro backdrop also matters. NURE's short-lease properties—especially hotels and apartments—benefit when rents can reset quickly during inflation, but they face sharper sensitivity to consumer demand and travel cycles. REET's broader footprint is influenced by global monetary policy divergence, currency movements, and regional real estate cycles. Sector risks common to both include refinancing costs, valuation pressure from higher long-term yields, and the potential for economic softening to weigh on tenant demand.
Over recent market cycles, the two funds have reflected their structural differences rather than tracking one another. NURE's concentrated, short-lease portfolio has historically shown greater sensitivity to apartment rent trends, hotel occupancy, and self-storage pricing power. Its smaller, U.S.-focused composition can produce sharper swings in both directions, with performance tied to a narrow set of property fundamentals.
REET, by contrast, has delivered steadier relative positioning driven by diversified sector exposure and global diversification. Its heavy weighting in healthcare, industrial, and data-center REITs has aligned it with secular demand themes, while its international sleeve moderates dependence on any single economy. On a cost and liquidity basis, REET holds a clear structural advantage, and its lower volatility profile has made it the more consistent vehicle for broad real estate allocation. NURE's appeal is tactical: a higher-octane, short-cycle bet for investors with a specific view on repricing in apartments and hospitality.
Tickeron's AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener is designed to surface trade ideas, trending names, and breakout candidates more efficiently than manual screening, helping investors narrow a broad universe into a focused watchlist. Explore the AI Screener to streamline your own ETF comparison and idea generation.
Based on observable structural factors, Tickeron's AI would likely favor REET in this comparison. REET offers superior cost efficiency at a 0.14% expense ratio, materially greater diversification across property types and geographies, deeper liquidity, and a lower-concentration risk profile. Its exposure to secularly favored sectors such as healthcare, industrial logistics, and data centers supports more consistent relative positioning. NURE remains a legitimate tactical vehicle for investors seeking concentrated, short-lease repricing exposure, but its narrow portfolio, higher fee, and smaller asset base present greater idiosyncratic risk. On balance, the AI verdict tilts toward REET as the more resilient and cost-effective core holding.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The 10-day moving average for NURE crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 17 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 89%.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
NURE moved above its 50-day moving average on October 16, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +0.74% 3-day Advance, the price is estimated to grow further. Considering data from situations where NURE advanced for three days, in 245 of 306 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
The Aroon Indicator entered an Uptrend today. In 180 of 253 cases where NURE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 71%.
The 10-day RSI Indicator for NURE moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 26 similar instances where the indicator moved out of overbought territory. In 22 of the 26 cases, the stock moved lower in the following days. This puts the odds of a move lower at 85%.
The Momentum Indicator moved below the 0 level on November 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NURE as a result. In 63 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 75%.
The Moving Average Convergence Divergence Histogram (MACD) for NURE turned negative on November 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 36 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 77%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NURE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
NURE broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The 10-day RSI Indicator for REET moved out of overbought territory on November 05, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 24 instances where the indicator moved out of the overbought zone. In 22 of the 24 cases the stock moved lower in the days that followed. This puts the odds of a move down at 90%.
The Momentum Indicator moved below the 0 level on November 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on REET as a result. In 62 of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 76%.
The Moving Average Convergence Divergence Histogram (MACD) for REET turned negative on November 18, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 35 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 74%.
The 50-day moving average for REET moved below the 200-day moving average on October 26, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where REET declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.
REET broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
REET moved above its 50-day moving average on October 30, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for REET crossed bullishly above the 50-day moving average on November 04, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 16 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Following a +2.77% 3-day Advance, the price is estimated to grow further. Considering data from situations where REET advanced for three days, in 247 of 307 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
The Aroon Indicator entered an Uptrend today. In 246 of 328 cases where REET Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 75%.
| NURE | REET | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 85% | 2 days ago 90% |
| Stochastic ODDS (%) | 2 days ago 75% | 2 days ago 78% |
| Momentum ODDS (%) | 2 days ago 75% | 2 days ago 76% |
| MACD ODDS (%) | 2 days ago 77% | 2 days ago 74% |
| TrendWeek ODDS (%) | 2 days ago 81% | 2 days ago 77% |
| TrendMonth ODDS (%) | 2 days ago 80% | 2 days ago 79% |
| Advances ODDS (%) | 4 days ago 80% | 16 days ago 80% |
| Declines ODDS (%) | 8 days ago 84% | 3 days ago 81% |
| BollingerBands ODDS (%) | 2 days ago 74% | 2 days ago 82% |
| Aroon ODDS (%) | 2 days ago 71% | 2 days ago 75% |
A.I.dvisor indicates that over the last year, NURE has been closely correlated with UDR. These tickers have moved in lockstep 83% of the time. This A.I.-generated data suggests there is a high statistical probability that if NURE jumps, then UDR could also see price increases.
| Ticker / NAME | Correlation To NURE | 1D Price Change % | ||
|---|---|---|---|---|
| NURE | 100% | +0.03% | ||
| UDR - NURE | 83% Closely correlated | +0.03% | ||
| MAA - NURE | 82% Closely correlated | -0.68% | ||
| CPT - NURE | 80% Closely correlated | -0.32% | ||
| ESS - NURE | 76% Closely correlated | +1.06% | ||
| VMRK - NURE | 75% Closely correlated | -0.78% | ||
More | ||||
A.I.dvisor indicates that over the last year, REET has been closely correlated with PLD. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if REET jumps, then PLD could also see price increases.
| Ticker / NAME | Correlation To REET | 1D Price Change % | ||
|---|---|---|---|---|
| REET | 100% | +0.22% | ||
| PLD - REET | 76% Closely correlated | -0.27% | ||
| KIM - REET | 74% Closely correlated | +0.23% | ||
| EXR - REET | 74% Closely correlated | +0.31% | ||
| SPG - REET | 73% Closely correlated | +0.50% | ||
| O - REET | 73% Closely correlated | +0.41% | ||
More | ||||